RAS interacts with AGO2 in the membrane component of the endoplasmic reticulum
The N terminus of AGO2 directly binds the Switch II domain of RAS
Oncogenic KRAS association inhibits AGO2-mediated microRNA duplex unwinding
AGO2 interaction elevates oncogenic KRAS levels to enhance cellular transformation